R-PHARM Acquires IXEMPRA(R) (ixabepilone) From Bristol-Myers Squibb and Launches U.S. Commercial Operations
August 17, 2015 08:30 ET
|
R-PHARM US, LLC
PRINCETON, N.J., Aug. 17, 2015 (GLOBE NEWSWIRE) -- R-PHARM US announces the acquisition of IXEMPRA (ixabepilone) from Bristol-Myers Squibb (NYSE:BMY). IXEMPRA received marketing approval from the U.S....